Patient explainer · Learn
Metagenomics
Metagenomics in Understanding the Gut-Brain Axis and Neurodegeneration
This is a detailed subject, and what it means for your situation depends on your history. Dr. Glowney is glad to work through it with you.
Metagenomics and the human microbiome.
Metagenomics, the study of the collective genomes of microorganisms in environmental samples, has emerged as a powerful scientific approach that is helping to decipher the complex interactions between hosts and their microorganisms (de Vos et al., 2022). This field has been particularly useful in human health, providing new information about the human microbiome, the collection of microorganisms that inhabit virtually all parts of the body (de Vos et al., 2022).
The human microbiome has been recognized as a critical player in maintaining homeostasis, influencing immune function, metabolism, and even brain health (Wang et al., 2015) (Cryan et al., 2019). Metagenomic studies have revealed that disruptions to the microbiome, known as dysbiosis, are associated with many diseases, including metabolic disorders, inflammatory bowel disease, cancers, and Parkinson's disease (de Vos et al., 2022) (Wallen et al., 2022).
The gut-brain axis and neurodegeneration.
The connection between metagenomics and neurodegeneration is a rapidly evolving area of research. Growing evidence suggests that the gut microbiome and its metabolites can influence brain health through bidirectional communication, commonly called the gut-brain axis. This axis includes complex interactions between the gut microbiota, the enteric nervous system, and the central nervous system, mediated by various pathways, including neural, endocrine, and immune mechanisms (Eshraghi, 2021) (Caspani et al., 2019).
Gut neuromicrobiology has emerged as an area of research that includes understanding the link between the gut microbiome, its neurometabolic interactome, and its association with brain health and diseases (Miri et al., 2023). Indeed, appreciable evidence indicates that the gut microbiome has been implicated in various neurological and psychiatric disorders, including Parkinson's disease, Alzheimer's disease, and depression (Caspani et al., 2019) (Cryan et al., 2019).
The critical role of the gut microbiota in maintaining resistance to infections and stimulating immunological and metabolic development has been well documented. In the brain, microbial metabolites may activate receptors on neurons or glia, modulate neuronal excitability, and change expression patterns through epigenetic mechanisms.
The microbiota's colonization of the human gut is an evolutionary process that impacts host physiology. It includes priming the immune system, aiding the breakdown of otherwise indigestible fibers, driving brain development, and shaping behavior. It is now well established that a bidirectional communication network exists between the gut and the brain, of which the microbiota and its metabolic output are a major component.
Early-life perturbations in the maturation of the microbiota can result in deficits in neurogenesis, axonal and dendritic growth, and synaptogenesis, which can negatively impact brain function and contribute to the development of neurological and psychiatric disorders (Caspani et al., 2019) (Rea et al., 2016).
Progress and open questions.
The field of metagenomics has provided new insights into the complex and dynamic interactions between the gut microbiome, the immune system, and the nervous system, which have implications for understanding a wide range of neurological and psychiatric conditions.
New sequencing technologies and culture-independent methods have allowed researchers to move beyond correlative studies toward mechanistic explorations of how the microbiome interacts with its host (Loh et al., 2024).
While significant progress has been made in understanding the role of the gut microbiome in neurological and psychiatric disorders, there are still many unanswered questions (Cenit et al., 2017). Further studies are warranted to establish whether the findings of preclinical animal experiments can be generalized to humans and to elucidate all the underlying mechanisms involved in the microbiota-gut-brain axis (Cenit et al., 2017).
The field of metagenomics has revolutionized our understanding of the critical role of the gut microbiome in human health, including its influence on brain function and the development of neurological and psychiatric disorders. Continued research in this rapidly evolving field holds great promise for developing novel therapeutic interventions targeting the microbiome-gut-brain axis to improve outcomes for individuals suffering from a wide range of neurological conditions.
Ultimately, the transformative insights gained from metagenomic studies have opened up new avenues for understanding and potentially managing neurodegeneration and other neurological disorders by targeting the gut microbiome (de Theije et al., 2014). Exploring the complex interactions between the gut microbiome and the brain is a promising avenue for the development of new diagnostic tools and therapeutic strategies.
Other conditions and possible clinical uses.
Beyond understanding the role of the gut microbiome in neurological disorders, metagenomic approaches have also provided valuable insights into the microbiome's involvement in various other diseases, including metabolic disorders, autoimmune diseases, and cancers.
The gut microbiome represents a new medical frontier, potentially transforming our understanding and treatment of various human health conditions.
Given the growing body of evidence linking the gut microbiome to brain health and neurological function, metagenomics holds significant promise for developing new diagnostic and therapeutic approaches for various neurological and psychiatric conditions.
Moreover, the emerging field of metagenomics has provided valuable insights into the complex interactions between the gut microbiome and the brain, paving the way for potential new avenues of treatment and management for a variety of neurological and mental health conditions (Cenit et al., 2017) (Mitrea et al., 2022).
The complexity of the gut-brain axis and the relationship between the gut microbiome and neurological function have captured the attention of researchers worldwide.
As research in metagenomics continues to progress, it is clear that the gut microbiome plays a crucial role in maintaining brain health and preventing the development of neurological and psychiatric disorders.
The field of metagenomics has revolutionized our understanding of the gut microbiome and its profound influence on human health, particularly in the context of neurological and psychiatric disorders.
References
Sources cited.
- Caspani, G., Kennedy, S., Foster, J. A., & Swann, J. (2019). Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microbial Cell, 6(10), 454–481. https://doi.org/10.15698/mic2019.10.693
- Cenit, M. C., Sanz, Y., & Codoñer-Franch, P. (2017). Influence of gut microbiota on neuropsychiatric disorders. World Journal of Gastroenterology, 23(30), 5486–5498. https://doi.org/10.3748/wjg.v23.i30.5486
- Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., Guzzetta, K. E., Jaggar, M., Long-Smith, C. M., Lyte, J. M., Martin, J. A., Molinero-Perez, A., Moloney, G., Morelli, E., Morillas, E., . . . Dinan, T. G. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877–2013. https://doi.org/10.1152/physrev.00018.2018
- de Theije, C. G., Wopereis, H., Ramadan, M., van Eijndthoven, T., Lambert, J., Knol, J., Garssen, J., Kraneveld, A. D., & Oozeer, R. (2014). Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain, Behavior, and Immunity, 37, 197–206. https://doi.org/10.1016/j.bbi.2013.12.005
- de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022). Gut microbiome and health: Mechanistic insights. Gut, 71(5), 1020–1032. https://doi.org/10.1136/gutjnl-2021-326789
- Eshraghi, A. A. (2021). Gut-brain connection, myth or reality? Role of the microbiome in health and diseases. World Scientific. https://doi.org/10.1142/11853
- Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024). Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduction and Targeted Therapy, 9(1), 37. https://doi.org/10.1038/s41392-024-01743-1
- Miri, S., Yeo, J., Abubaker, S., & Hammami, R. (2023). Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome? Frontiers in Microbiology, 14, 1098412. https://doi.org/10.3389/fmicb.2023.1098412
- Mitrea, L., Nemeş, S. A., Szabo, K., Teleky, B. E., & Vodnar, D. C. (2022). Guts imbalance imbalances the brain: A review of gut microbiota association with neurological and psychiatric disorders. Frontiers in Medicine, 9, 813204. https://doi.org/10.3389/fmed.2022.813204
- Rea, K., Dinan, T. G., & Cryan, J. F. (2016). The microbiome: A key regulator of stress and neuroinflammation. Neurobiology of Stress, 4, 23–33. https://doi.org/10.1016/j.ynstr.2016.03.001
- Wallen, Z. D., Demirkan, A., Twa, G., Cohen, G., Dean, M. N., Standaert, D. G., Sampson, T. R., & Payami, H. (2022). Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms. Nature Communications, 13(1), 6958. https://doi.org/10.1038/s41467-022-34667-x
- Wang, W. L., Xu, S. Y., Ren, Z. G., Tao, L., Jiang, J. W., & Zheng, S. S. (2015). Application of metagenomics in the human gut microbiome. World Journal of Gastroenterology, 21(3), 803–814. https://doi.org/10.3748/wjg.v21.i3.803
Related patient explainers